Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Cat. No. : CSC-RT0345
Target Gene : FXYD5 Host Cell : 293T
Size : >1x106 cells/vial Validation : Sequencing
| Cat. No. | CSC-RT0345 |
| Description | 293T-FXYD5 (-/-) is a stable cell line with a homozygous knockout of human FXYD5 |
| Target Gene | FXYD5 |
| Host Cell | 293T |
| Host Cell Species | Homo sapiens (Human) |
| Size | >1x106 cells/vial |
| Validation | Sequencing |
| Revival | Rapidly thaw cells in a 37°C water bath. Transfer contents into a tube containing pre-warmed media. Centrifuge cells and seed into a 25 cm2 flask containing pre-warmed media. |
| Mycoplasma | Negative |
| Format | One frozen vial containing millions of cells |
| Storage | Liquid nitrogen |
| Safety Considerations |
The following safety precautions should be observed. 1. Use pipette aids to prevent ingestion and keep aerosols down to a minimum. 2. No eating, drinking or smoking while handling the stable line. 3. Wash hands after handling the stable line and before leaving the lab. 4. Decontaminate work surface with disinfectant or 70% ethanol before and after working with stable cells. 5. All waste should be considered hazardous. 6. Dispose of all liquid waste after each experiment and treat with bleach. |
| Ship | Dry ice |
This gene encodes a member of a family of small membrane proteins that share a 35-amino acid signature sequence domain, beginning with the sequence PFXYD and containing 7 invariant and 6 highly conserved amino acids. The approved human gene nomenclature for the family is FXYD-domain containing ion transport regulator. Mouse FXYD5 has been termed RIC (Related to Ion Channel). FXYD2, also known as the gamma subunit of the Na,K-ATPase, regulates the properties of that enzyme. FXYD1 (phospholemman), FXYD2 (gamma), FXYD3 (MAT-8), FXYD4 (CHIF), and FXYD5 (RIC) have been shown to induce channel activity in experimental expression systems. Transmembrane topology has been established for two family members (FXYD1 and FXYD2), with the N-terminus extracellular and the C-terminus on the cytoplasmic side of the membrane. This gene product, FXYD5, is a glycoprotein that functions in the up-regulation of chemokine production, and it is involved in the reduction of cell adhesion via its ability to down-regulate E-cadherin. It also promotes metastasis, and has been linked to a variety of cancers. Alternative splicing results in multiple transcript variants. [RefSeq curation by Kathleen J. Sweadner, Ph.D., sweadner@helix.mgh.harvard.edu., Sep 2009]
A: The knockout cell product is validated by PCR amplification and Sanger Sequencing to confirm the mutation at the genomic level. Please find the detailed mutation info in the datasheet.
A: Single clonal cell.
A: No. This knockout cell product is generated using the CRISPR/Cas9 system to induce small insertions or deletions (indels) resulting in frameshift mutations. Although these frameshift mutations typically disrupt the coding gene, there is a possibility that the non-functional transcript may still be transcribed. Consequently, this could potentially yield misleading results when analyzed by RT-qPCR.
A: The cell line should be stored in liquid nitrogen for long-term preservation.
A: For most cases, we often keep at least 2 clones with different frameshift mutations. Please feel free to contact us to check if there are additional available clones.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
The efficiency with which FXYD5 Knockout Cell Line-293T achieves gene knockout has saved me valuable time, allowing me to focus on analyzing results and drawing meaningful conclusions from my experiments.
Through its exceptional performance, FXYD5 Knockout Cell Line-293T has opened up new possibilities for my research, allowing me to explore complex genetic interactions and contribute to a deeper understanding of cellular mechanisms.
The high success rate of gene knockout achieved with FXYD5 Knockout Cell Line-293T has been critical in obtaining statistically robust data, strengthening the scientific rigor of my studies and elevating the impact of my research.
FXYD5 Knockout Cell Line-293T's consistent and reliable performance has also earned praise from my peers, who have recognized the value of this gene knockout reagent and its instrumental role in advancing our collective knowledge in the field of genetics.
In a fast-paced and competitive scientific landscape, FXYD5 Knockout Cell Line-293T has proven to be an invaluable asset, equipping me with the tools necessary to push the boundaries of genetic research and make significant contributions to the scientific community.
FXYD5 Knockout Cell Line-293T's straightforward operation simplifies complex gene editing, optimizing my research efficiency and ensuring accuracy in experiments.
Consistent successful knockouts validate FXYD5 Knockout Cell Line-293T's role as a dependable genetic research tool, reinforcing the credibility and robustness of my findings.
Versatility in applications across multiple research fields promises innovation, progress, and potential breakthroughs in diverse scientific domains.
Write a review of your use of Biogene products and services in your research. Your review can help your fellow researchers make informed purchasing decisions.